 Tree MATA modified pollen allergen tyrosine adsorbate has been developed to provide pre-seasonal specific immunotherapy for patients with hypersensitivity to tree birch, alder, and hazel pollen. Different doses of Tree MATA will be administered and immunological changes following this treatment will be assessed. 